Haleon (LON:HLN) Sets New 52-Week High – Here’s What Happened

Haleon plc (LON:HLN) reached a new 52-week high on Thursday . The stock traded as high as GBX 431.82 ($5.61) and last traded at GBX 394.10 ($5.12), with a volume of 65438391 shares trading hands. The stock had previously closed at GBX 388.20 ($5.04).

Wall Street Analyst Weigh In

Separately, Berenberg Bank increased their price objective on Haleon from GBX 456 ($5.92) to GBX 457 ($5.93) and gave the stock a “buy” rating in a report on Friday, February 28th.

Haleon Trading Up 1.4 %

The stock’s fifty day simple moving average is GBX 388.17 and its two-hundred day simple moving average is GBX 381.73. The firm has a market cap of £35.52 billion, a PE ratio of 33.10, a PEG ratio of 1.49 and a beta of 0.19. The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36.

Haleon (LON:HLN) last posted its quarterly earnings results on Friday, February 28th. The company reported GBX 15.80 ($0.21) earnings per share for the quarter. Haleon had a return on equity of 6.54% and a net margin of 9.66%. On average, sell-side analysts forecast that Haleon plc will post 19.5033282 EPS for the current fiscal year.

Haleon Increases Dividend

The business also recently declared a dividend, which will be paid on Thursday, June 5th. Stockholders of record on Thursday, April 24th will be given a GBX 4.60 ($0.06) dividend. This represents a dividend yield of 1.18%. The ex-dividend date of this dividend is Thursday, April 24th. This is a positive change from Haleon’s previous dividend of $2.00. Haleon’s payout ratio is currently 50.46%.

About Haleon

Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges.

Haleon’s portfolio spans five global categories including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health and Digestive Health and other.